Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Am J Kidney Dis. 2011 Aug 27;58(5):746–755. doi: 10.1053/j.ajkd.2011.06.021

Table 2.

Frequencies and Event Rates for Outcomes, by eGFR category

Short-Term (30 d) Long-Term (3 y)
Frequency (%) Event Rate Frequency (%) Event Rate
Recurrent VTE
eGFR< 30 8 (6.6) 101.9 23 (18.9) 15.9
eGFR=30-59 26 (6.0) 84.9 57 (13.2) 8.2
eGFR=60-89 24 (4.2) 56.9 74 (12.9) 7.5
eGFR ≥ 90 23 (6.1) 81.0 60 (15.8) 8.4
Major Bleeding Episodes
eGFR< 30 18 (14.8) 246.3 30 (24.6) 23.2
eGFR=30-59 29 (6.7) 95.9 64 (14.8) 9.1
eGFR=60-89 55 (9.6) 136.9 71 (12.4) 7.1
eGFR ≥ 90 21 (5.5) 74.2 34 (9.0) 4.6
All-Cause Mortality
eGFR< 30 28 (23.0) 340.6 86 (70.5) 52.5
eGFR=30-59 55 (12.7) 170.4 206 (47.7) 24.7
eGFR=60-89 59 (10.3) 134.9 228 (39.7) 19.0
eGFR ≥ 90 18 (4.7) 60.1 111 (29.2) 12.5

Note: event rates are shown per 100 person-years. eGFR given in mL/min/1.73 m2 (factor for conversion factor to ml/s/1.73 m2, ×0.01667).

Abbreviations: eGFR, estimated glomerular filtration rate; VTE, venous thromboembolism.